My Comfort history record.. 1st round bought 0.80 & sold 7.25 profit 1 rumah batu, 2nd round loss 1 Vios model baru, 3rd round NOW average 2.88... hope take back my Vios... hahaha
Following the uplifting of the regulated short selling (RSS) suspension, glove makers under our coverage came under heavy selling pressure, with respective share prices declining by 10% to 14% overnight. We are of the view that the extended selldown is rather unwarranted, considering that the fundamentals for glove counters are still intact and stellar results are still expected in the coming quarters, supported by rising gloves’ ASP and tight supplies due to capacity constraints. .
1-No change to fundamentals
Still sound. Despite the unwarranted heavy selldown on glove counters following the uplifting of RSS suspension, fundamentals for the glove makers under our coverage universe remain solid. We expect the glove makers to continue delivering impressive results in the coming quarters. We see an upward ASP trend as the rubber glove supplies continue to be tight due to capacity constraints.
2-Vaccine is not wonder drug.
The rollout of Covid-19 vaccine has greatly dampened the sentiment on glove counters; however, we highlight that glove demand and ASPs are still holding up well, considering the change in consumption pattern and heightened hygiene awareness. On a side note, with the new Covid strain that is reportedly faster spreading, the existing vaccines developed might not work as effectively in warding off the new strain, potentially prolonging the time needed to inoculate a sufficient percentage of the world population.
3-Buy for its dividends.
Top Glove has committed to special dividend payout of 20%, bringing its total dividend payout for the remaining three quarters in FY21F to 70%.
4-Attractive valuations,
upgrade to Overweight. Following the recent share price retracement, all three glove makers under our coverage are currently trading at compelling valuation levels.
The following are 2 Analyst report for 2 companies (Boxed in Yellow) in India.
I only want to point out the twisted rationale of the Analysts Reports being floated about Glove companies.
1. Granules India Limited (Pharma Company). No they don't produce Vaccines. The Analyst has estimated an Earnings(EPS) increase of 21% for FY 2021/2022 (The EPS growth is Annual) They assign a PE of 16.
2. Trident Limited (The largest Terry Towel & Bed Linen manufacturer in the world) The Analyst has estimated an Earnings(EPS) increase of 38% for FY 2021 & 15% for FY 2022. They assign a Forward PE for FY 2022 of 11. (The EPS growth is Annual)
Within all glove counters, CB Comfort had the worst performance. Anyway to fxxk off all directors ?? wish to get few bangla and hug the directors for 10mins!
Post a Comment
People who like this
New Topic
You should check in on some of those fields below.
Title
Category
Comment
Confirmation
Click Confirm to delete this Forum Thread and all the associated comments.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
True
329 posts
Posted by True > 2021-01-04 14:43 | Report Abuse
So cheap d . Just hold lo . Better than go play penny stock which need to monitor every single second